Related Experiment Videos
Population screening for congenital hypothyroidism
Insights
A pilot program screened 87,444 babies for congenital hypothyroidism, detecting 26 cases. Early diagnosis through screening significantly improved prognosis for affected infants, advocating for national implementation.
Area of Science:
- Neonatal screening
- Endocrinology
- Public health
Background:
- Congenital hypothyroidism (CH) is a common endocrine disorder in newborns.
- Early diagnosis and treatment are crucial to prevent irreversible developmental delays.
- Existing clinical detection methods for CH have limitations.
Purpose of the Study:
- To evaluate the effectiveness of a pilot newborn screening program for CH.
- To determine the incidence of CH in a defined geographical area.
- To assess the impact of screening on early diagnosis and treatment.
Main Methods:
- A pilot screening program for CH was implemented across North London, Essex, Bedfordshire, and Hertfordshire.
- Thyroid-stimulating hormone (TSH) levels were measured from dried blood spots (Guthrie cards).
- Screening data from 87,444 infants over one year were analyzed.
Main Results:
- A total of 26 cases of primary CH were detected, yielding an incidence of 1:3363.
- Only 7.7% of cases were diagnosed clinically prior to screening results.
- The program facilitated early treatment for 22 infants, including 8 with previously undetected severe symptoms.
Conclusions:
- Newborn screening for CH is highly effective in identifying affected infants early.
- Screening significantly improves the timeliness of diagnosis and treatment initiation.
- The findings support the urgent implementation of a national CH screening program.
Abstract:
A pilot screening programme for congenital hypothyroidism covering most of North London, Essex, Bedfordshire, and Hertfordshire entailed carrying out an assay of thyroid-stimulating hormone on single Guthrie dried blood spots. During one year 87 444 babies were screened and 26 cases of primary congenital hypothyroidism detected, giving an incidence of 1:3363. Only two cases (7.7%) had already been diagnosed on clinical grounds before the results of screening became available. In two other babies the diagnosis was delayed. The programme thus resulted in the early treatment of 22 babies, eight of whom already had pronounced features of hypothyroidism that had not been detected on routine clinical examinations. Although definitive evidence will not be available for some years, the results suggest that the prognosis for most of these babies is likely to be improved by early diagnosis; thus the introduction of national screening should be delayed no longer.